These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35725428)

  • 1. Identifying the factors promoting colorectal cancer screening uptake in Hong Kong using Andersen's behavioural model of health services use.
    Chan DNS; Choi KC; Au DWH; So WKW
    BMC Public Health; 2022 Jun; 22(1):1228. PubMed ID: 35725428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does theory of planned behaviour play a role in predicting uptake of colorectal cancer screening? A cross-sectional study in Hong Kong.
    Huang J; Wang J; Pang TW; Chan MK; Leung S; Chen X; Leung C; Zheng ZJ; Wong MC
    BMJ Open; 2020 Aug; 10(8):e037619. PubMed ID: 32764087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation in a government-subsidised colorectal cancer screening programme for asymptomatic individuals in Hong Kong.
    Chan DNS; So WKW; Choi KC
    Cancer Epidemiol; 2022 Aug; 79():102174. PubMed ID: 35533550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of participation in faecal occult blood testing and screening colonoscopy after health education in Hong Kong.
    Wong BC; Chan AO; Wong KW; Ching CK; Wong WM; Tam S; Lai KC; Chan CK; Yuen MF; Lam SK
    Eur J Cancer Prev; 2005 Apr; 14(2):181-4. PubMed ID: 15785323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
    Wong CK; Lam CL; Wan YF; Fong DY
    BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese.
    Wong MC; Tsoi KK; Ng SS; Lou VW; Choi SY; Ling KW; Chan FK; Griffiths SM; Sung JJ
    Aliment Pharmacol Ther; 2010 Jul; 32(1):74-82. PubMed ID: 20345501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong.
    Wong MC; Ching JY; Lam TY; Luk AK; Hirai HW; Griffiths SM; Chan FK; Sung JJ
    Prev Med; 2013 Sep; 57(3):227-31. PubMed ID: 23732241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial.
    Robertson DJ; Dominitz JA; Beed A; Boardman KD; Del Curto BJ; Guarino PD; Imperiale TF; LaCasse A; Larson MF; Gupta S; Lieberman D; Planeta B; Shaukat A; Sultan S; Menees SB; Saini SD; Schoenfeld P; Goebel S; von Rosenvinge EC; Baffy G; Halasz I; Pedrosa MC; Kahng LS; Cassim R; Greer KB; Kinnard MF; Bhatt DB; Dunbar KB; Harford WV; Mengshol JA; Olson JE; Patel SG; Antaki F; Fisher DA; Sullivan BA; Lenza C; Prajapati DN; Wong H; Beyth R; Lieb JG; Manlolo J; Ona FV; Cole RA; Khalaf N; Kahi CJ; Kohli DR; Rai T; Sharma P; Anastasiou J; Hagedorn C; Fernando RS; Jackson CS; Jamal MM; Lee RH; Merchant F; May FP; Pisegna JR; Omer E; Parajuli D; Said A; Nguyen TD; Tombazzi CR; Feldman PA; Jacob L; Koppelman RN; Lehenbauer KP; Desai DS; Madhoun MF; Tierney WM; Ho MQ; Hockman HJ; Lopez C; Carter Paulson E; Tobi M; Pinillos HL; Young M; Ho NC; Mascarenhas R; Promrat K; Mutha PR; Pandak WM; Shah T; Schubert M; Pancotto FS; Gawron AJ; Underwood AE; Ho SB; Magno-Pagatzaurtundua P; Toro DH; Beymer CH; Kaz AM; Elwing J; Gill JA; Goldsmith SF; Yao MD; Protiva P; Pohl H; Kyriakides T;
    JAMA Netw Open; 2023 Jul; 6(7):e2321730. PubMed ID: 37432690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening behaviour and associated factors among Chinese aged 50 and above in Hong Kong - a population-based survey.
    So WK; Choi KC; Chan DN; Shiu AT; Ho SS; Chan HY; Lam WW; Cheng KK; Goggins W; Chan CW
    Eur J Oncol Nurs; 2012 Sep; 16(4):413-8. PubMed ID: 22036772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition to quantitative faecal immunochemical testing from guaiac faecal occult blood testing in a fully rolled-out population-based national bowel screening programme.
    Clark G; Strachan JA; Carey FA; Godfrey T; Irvine A; McPherson A; Brand J; Anderson AS; Fraser CG; Steele RJ
    Gut; 2021 Jan; 70(1):106-113. PubMed ID: 32234803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China.
    Wang L; Chen H; Zhu Y; Lu M; Wang Y; Chen X; Ma W; Du L; Chen W
    BMJ Open; 2022 May; 12(5):e059754. PubMed ID: 35589365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in the use of colorectal cancer tests among older Chinese adults.
    Choi KC; So WK; Chan DN; Shiu AT; Ho SS; Chan HY; Lam WW; Cheng KK; Goggins WB; Chan CW
    Eur J Oncol Nurs; 2013 Oct; 17(5):603-9. PubMed ID: 23462304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.